Overview
Study start-up (SSU) for randomized controlled trials is usually a long and costly process that can cause significant delays.
Addressing this challenge, CTTI conducted work to identify specific metrics and benchmarks related to SSU, recommending greater standardization within the clinical trials ecosystem. More recently, it also conducted research and released a report showing that budgets and contracts are significant contributors to delays, laying the groundwork for future industry work on remodeling the SSU process.
Solutions
Search AllRecommendation Summary
Recommendations
Resources
Related Items
News
- CTTI Report Finds Contracting and Budgeting are Significant Pain Points for Study Start-UpIt’s no secret that the entire clinical trials ecosystem is affected by painfully slow study start-up timelines. CTTI recently sought to investigate the factors that influence this crucial problem. After ...